42 results match your criteria: "Toronto Centre for Advanced Reproductive Technology[Affiliation]"
J Obstet Gynaecol Can
December 2017
Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada; Toronto Centre for Advanced Reproductive Technology, Toronto, ON, Canada.
J Obstet Gynaecol Can
September 2017
Directeur médical, Toronto Centre for Advanced Reproductive Technology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario.
J Obstet Gynaecol Can
September 2017
Medical Director, Toronto Centre for Advanced Reproductive Technology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON.
Fertil Steril
April 2015
Department of Obstetrics and Gynecology, Division of Reproductive Sciences, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Toronto Centre for Advanced Reproductive Technology (TCART) Fertility Partners, Toronto, Ontario, Canada.
Fertil Steril
April 2015
Division of Reproductive Sciences, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, and Toronto Centre for Advanced Reproductive Technology Fertility Partners, Toronto, Ontario, Canada. Electronic address:
A single bolus of human chorionic gonadotropin (hCG) at midcycle has been the gold standard for triggering final oocyte maturation and ovulation in assisted reproductive technology cycles. More recently, gonadotropin-releasing hormone (GnRH)-agonist (GnRH-a) triggering has been introduced. The GnRH-a trigger may allow a more physiologic surge of both luteinizing hormone (LH) and follicle-stimulating hormone, although whether the combined surge will result in improved oocyte and embryo quality remains to be seen.
View Article and Find Full Text PDFReprod Biomed Online
April 2015
Toronto Centre for Advanced Reproductive Technology, M5X 2S9, Toronto, Ontario, Canada; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Electronic address:
The aim of this case series study was to investigate the effect of adjusting the length of progesterone exposure on clinical pregnancy rates in cryopreserved embryo transfer cycles of patients with out-of-phase classic endometrial dating. Eighty infertile women with previous implantation failure and good-quality embryos underwent endometrial biopsy before cryopreserved embryo transfer and were included in this study. The main outcome measures were clinical pregnancy rate and histologic endometrial dating.
View Article and Find Full Text PDFClin Med Insights Reprod Health
July 2014
Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada. ; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada. ; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
Background: The age-related reduction in live-birth rate is attributed to a high rate of aneuploidy and follicle depletion. We showed in an animal model that treatment with Coenzyme Q10 (CoQ10) markedly improved reproductive outcome. The aim of this study was to compare the post-meiotic oocyte aneuploidy rate in in vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI) patients treated with CoQ10 or placebo.
View Article and Find Full Text PDFEndocrinology
July 2014
Toronto Centre for Advanced Reproductive Technology Fertility Partners, Toronto, Ontario, Canada M5S 2X9; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada M5X 2X9; and Lunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital, Toronto, Ontario, Canada M5G 1X5.
Fertil Steril
June 2014
Division of Urology, Department of Surgery, Royal Victoria Hospital, McGill University Health Center, Montreal, Quebec, Canada. Electronic address:
Objective: To investigate the association between seminal hyperviscosity, the extent of semenogelin degradation, and sperm DNA integrity (DNA fragmentation index [DFI] and high DNA stainability [HDS]) in semen from infertile couples.
Design: Prospective study.
Setting: University-affiliated fertility center.
Fertil Steril
March 2014
Toronto Centre for Advanced Reproductive Technology, Lunenfeld-Tanenbaum Research Institute, and Division of Reproductive Sciences, University of Toronto, Toronto, Ontario, Canada.
Reprod Biol Endocrinol
February 2013
Toronto Centre for Advanced Reproductive Technology, Toronto, ON, Canada.
Background: When stimulating a patient with poor ovarian response for IVF, the maximal dose of gonadotropins injected is often determined by arbitrary standards rather than a measured response. The purpose of this study was to determine if serum FSH concentration during an IVF stimulation cycle reflects follicular utilization of FSH and whether serum FSH values may inform dose adjustments of exogenous FSH.
Methods: In this retrospective cross sectional study we studied 155 consecutive IVF cycles stimulated only with recombinant human FSH.
Fertil Steril
January 2013
Toronto Centre for Advanced Reproductive Technology, Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, and Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Electronic address:
In recent years, social and cultural trends have resulted in women delaying childbirth, thereby leading to reproductive senescence as a growing public health problem. We discuss potential etiologies for age-related female reproductive decline. We bring supportive evidence to the central role of mitochondrial dysfunction and oxygen radicals in the process of aging in general and reproductive senescence specifically.
View Article and Find Full Text PDFReprod Biol Endocrinol
August 2012
Toronto Centre for Advanced Reproductive Technology, M5X 2 S9 Toronto, ON, Canada.
Background: To compare the outcome of IVF cycles in women receiving controlled ovarian stimulation with recFSH or recFSH plus low dose hCG.
Methods: A retrospective case control study, performed at a private practice affiliated with an academic institute. Patients were infertile women who were treated with IVF/ICSI and controlled ovarian stimulation in a long GnRH agonist protocol using either low dose hCG in addition to recFSH [N = 88] or recFSH alone [N = 99].
Obstet Gynecol
August 2012
Reproductive Biology, Toronto Centre for Advanced Reproductive Technology, the Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and the Department of Obstetrics and Gynecology, the Institute of Medical Sciences, and the Division of Reproductive Sciences, University of Toronto, Toronto, Ontario, Canada.
Objective: To estimate whether there is any association of long-term use of combined oral contraceptive pills (OCP) with adverse endometrial growth.
Methods: We reviewed the charts of 137 patients with history of OCP use undergoing endometrial preparation with estrogen for frozen embryo transfer. Endometrial thickness was measured by transvaginal ultrasonography on day 10 after menses and patients were divided into two groups (less than 7 mm and 7 mm or more).
Fertil Steril
May 2012
Toronto Centre for Advanced Reproductive Technology, University of Toronto, Toronto, Ontario, Canada.
Objective: To study the cause for poor oocyte yield, amenorrhea, and recurrent pregnancy loss in a patient undergoing IVF.
Design: Case report.
Setting: University-affiliated private IVF clinic.
The objective of this study was to determine the effects of low-level laser light exposure on the motility of spermatozoa and on DNA damage. Thirty-three semen samples were collected for routine analysis and were classified as normospermic, oligospermic, or asthenospermic. After routine semen analysis was performed, residual semen was divided into treated and control aliquots.
View Article and Find Full Text PDFJ Assist Reprod Genet
September 2011
Toronto Centre for Advanced Reproductive Technology, University of Toronto, Toronto, Ontario, Canada.
Purpose: The number of women attempting to conceive between the ages of 36 and 44 has increased significantly in the last decade. While it is well established that women's reproductive success dramatically declines with age, the underlying physiological changes responsible for this phenomenon are not well understood. With assisted reproductive technologies, it is clear that oocyte quality is a likely cause since women over 40 undergoing in vitro fertilization (IVF) with oocytes donated by younger women have success rates comparable to young patients.
View Article and Find Full Text PDFFertil Steril
June 2011
Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada.
The use of a letrozole challenge test to predict ovarian response is described. The authors show that a ratio of cycle day 7 to cycle day 3 post-letrozole FSH level >1.5 is associated with poor ovarian response.
View Article and Find Full Text PDFFertil Steril
March 2011
Toronto Centre for Advanced Reproductive Technology, Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
Nimodipine, a calcium-channel blocker that can cross the blood-brain barrier, has been shown to inhibit pulsatile GnRH release in vitro. We now show that oral nimodipine can effectively inhibit the ovarian cycle in mice in a dose-related manner.
View Article and Find Full Text PDFJ Assist Reprod Genet
February 2011
Toronto Centre for Advanced Reproductive Technology, University of Toronto, 210-150 Bloor Street West, Toronto, ON, M5S 2X9, Canada.
Purpose: The negative correlation between fecundity and age in women has been extensively documented although data on reproductive performance in very young women is sparse. The objective of this study was to determine whether age ≤25 years has an impact on reproductive outcome in women undergoing IVF-ET.
Methods: IVF outcome in 85 infertility patients aged 19-25 years was compared to that in 69 infertility patients aged 30-35 years.
Reprod Biomed Online
January 2010
Toronto Centre for Advanced Reproductive Technology (TCART), 210-150 Bloor Street (W), Toronto, Ont., Canada M5S 2X9.
Intracytoplasmic sperm injection (ICSI) has resulted in pregnancy and birth for many couples, including those with severe male factor infertility. However, even after ICSI, complete failure of fertilization occurs in 1-3% of cycles. Most cases occur due to low number of mature oocytes, failure of oocyte activation or non-availability of appropriate spermatozoa for injection.
View Article and Find Full Text PDFFertil Steril
October 2010
Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada.
CD56(bright)CD16(-) natural killer (NK) cells that express CXCR3 accumulate in the follicular fluid of patients with a good response to ovarian stimulation. It is conceivable that granulosa cells of good responders that express the chemokine CXCL10 recruit these NK cells to support follicular angiogenesis.
View Article and Find Full Text PDFObjective: To report an ongoing pregnancy after in vitro fertilization (IVF) with ovarian stimulation using a gonadotropin-releasing hormone (GnRH) antagonist that resulted in two waves of follicular growth.
Design: Case report.
Setting: University of Toronto affiliated infertility clinic.
Fertil Steril
January 2010
Toronto Centre for Advanced Reproductive Technology, University of Toronto, Toronto, Ontario, Canada.
We present a hypothesis emphasizing the role of mitochondrial dysfunction in reproductive senescence and suggesting the use of mitochondrial nutrients as an adjuvant treatment in older patients with infertility.
View Article and Find Full Text PDFFertil Steril
September 2009
Toronto Centre for Advanced Reproductive Technology, University of Toronto, Toronto, Ontario, Canada; Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada.
Objective: To report two cases of successful monozygotic twin pregnancies in women undergoing infertility treatment and to review possible etiologic factors.
Design: Case report and review of the literature.
Setting: University of Toronto-affiliated infertility clinic.